Survival outcomes in a prospective randomized multicenter phase III trial comparing patients undergoing anatomical segmentectomy versus standard lobectomy for non-small cell lung cancer up to 2 cm - Stamatis, G; Leschber, G; Schwarz, B (Lung Cancer, 2022)